Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

Clinical trial NCT02993146 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02993146
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm Metastatic Malignant Neoplasm in the Brain

Start date: 2017-05-08
Primary completion: 2022-08-19
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.